United States Steel Corp. is a steel manufacturer in the United States. It produces and sells steel mill products including flat-rolled and tubular products in North America and Europe. United States Steel reports in five segments - Flat-Rolled Product, Mini Mill, U.S. Steel Europe, Tubular Products and Other Businesses. Flat-Rolled Product segment manufactures sheets, plates and tin mill products for the automotive, appliance, service center, conversion, container and construction markets. Mini Mill segment was added after purchase Big River Steel. USSE - Sells sheets, plates, tin mills, tubulars, precision tubes, specialty steel products and coke to end-markets in Europe. Tubular Products segment provides seamless and electric resistant welded tubular products to the oil, gas and petrochemical markets. Other Businesses segment is involved in the production and sale of iron-bearing taconite pellets, transportation services, management and development of real estate and engineering and consulting services....
+See More2023-02-28 10:27:00 Tuesday ET

Basic income reforms can contribute to better health care, public infrastructure, education, technology, and residential protection. Philippe Van Parijs
2019-10-27 17:37:00 Sunday ET

International climate change can cause an adverse impact on long-term real GDP economic growth. USC climate change economist Hashem Pesaran and his co-autho
2018-05-06 07:30:00 Sunday ET

President Trump withdraws America from the Iran nuclear agreement and revives economic sanctions on Iran for better negotiations as western allies Britain,
2017-11-25 06:34:00 Saturday ET

Mario Draghi, President of the European Central Bank, heads the international committee of financial supervisors and has declared their landmark agreement o
2019-04-19 12:35:00 Friday ET

Federal Reserve proposes to revamp post-crisis rules for U.S. banks. The current proposals would prescribe materially less strict requirements for community
2018-05-07 07:32:00 Monday ET

President Trump seeks to honor his campaign promise of lower U.S. medical costs by forcing higher big-pharma prices in foreign countries such as Canada, Bri